221 related articles for article (PubMed ID: 14747552)
1. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.
Li J; Tong S; Lee HB; Perdigoto AL; Spangenberg HC; Wands JR
J Virol; 2004 Feb; 78(4):1873-81. PubMed ID: 14747552
[TBL] [Abstract][Full Text] [Related]
2. Initiation of duck hepatitis B virus infection requires cleavage by a furin-like protease.
Tong Y; Tong S; Zhao X; Wang J; Jun J; Park J; Wands J; Li J
J Virol; 2010 May; 84(9):4569-78. PubMed ID: 20181690
[TBL] [Abstract][Full Text] [Related]
3. Identification and expression of glycine decarboxylase (p120) as a duck hepatitis B virus pre-S envelope-binding protein.
Li J; Tong S; Wands JR
J Biol Chem; 1999 Sep; 274(39):27658-65. PubMed ID: 10488106
[TBL] [Abstract][Full Text] [Related]
4. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein.
Urban S; Gripon P
J Virol; 2002 Feb; 76(4):1986-90. PubMed ID: 11799193
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.
Pugh JC; Di Q; Mason WS; Simmons H
J Virol; 1995 Aug; 69(8):4814-22. PubMed ID: 7609048
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of binding peptides on replication of duck hepatitis B virus].
Jia HY; Chen Z; Zhou LF; Chen F; Zhu HH; Liu JH; Xu XY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):116-20. PubMed ID: 15812883
[TBL] [Abstract][Full Text] [Related]
9. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
10. Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress.
Funk A; Hohenberg H; Mhamdi M; Will H; Sirma H
J Virol; 2004 Apr; 78(8):3977-83. PubMed ID: 15047813
[TBL] [Abstract][Full Text] [Related]
11. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
12. Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.
Dallmeier K; Schultz U; Nassal M
PLoS Pathog; 2008 Dec; 4(12):e1000230. PubMed ID: 19057662
[TBL] [Abstract][Full Text] [Related]
13. Viral and cellular determinants involved in hepadnaviral entry.
Glebe D; Urban S
World J Gastroenterol; 2007 Jan; 13(1):22-38. PubMed ID: 17206752
[TBL] [Abstract][Full Text] [Related]
14. A short sequence within domain C of duck carboxypeptidase D is critical for duck hepatitis B virus binding and determines host specificity.
Spangenberg HC; Lee HB; Li J; Tan F; Skidgel R; Wands JR; Tong S
J Virol; 2001 Nov; 75(22):10630-42. PubMed ID: 11602705
[TBL] [Abstract][Full Text] [Related]
15. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.
Klingmüller U; Schaller H
J Virol; 1993 Dec; 67(12):7414-22. PubMed ID: 8230462
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates.
Maenz C; Loscher C; Iwanski A; Bruns M
J Gen Virol; 2008 Dec; 89(Pt 12):3016-3026. PubMed ID: 19008388
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression and purification of duck hepatitis B virus (DHBV) core protein and its use in the development of an indirect ELISA for serologic detection of DHBV infection.
Liu Q; Jia R; Wang M; Huang J; Zhu D; Chen S; Yin Z; Wang Y; Chen X; Cheng A
Arch Virol; 2014 May; 159(5):897-904. PubMed ID: 24158348
[TBL] [Abstract][Full Text] [Related]
19. Carboxypeptidase D is an avian hepatitis B virus receptor.
Tong S; Li J; Wands JR
J Virol; 1999 Oct; 73(10):8696-702. PubMed ID: 10482623
[TBL] [Abstract][Full Text] [Related]
20. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
Li J; Tong S
Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
